Literature DB >> 24210828

The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin.

Hólmfridur Helgadóttir1, David C Metz2, Yu-Xiao Yang3, Andrew D Rhim3, Einar S Björnsson4.   

Abstract

BACKGROUND: Dyspepsia develops in healthy volunteers after withdrawal of proton-pump inhibitors. This phenomenon, attributed to rebound acid hypersecretion, is thought to be mediated by reflex hypergastrinemia. AIMS: To measure fasting and postprandial gastrin in patients on long-term proton-pump inhibitor treatment and correlate gastrin levels with the duration of treatment and other potential predictors.
METHODS: In this cross sectional study patients, with erosive esophagitis, on long-term proton-pump inhibitor treatment and healthy controls underwent gastrin measurements at baseline and four times following a meal and Helicobacter pylori status was determined.
RESULTS: A total of 100 patients and 50 controls were studied. Pre- and postprandial gastrin levels were higher in patients (p<0.001). No significant correlation was found between the area under the gastrin-curve and the treatment duration. Female patients had significantly higher gastrin levels than males pre- and postprandial, whereas such differences was not found in the control group. Female gender was the only independent predictor of s-gastrin levels (OR 2.50 compared to males, 95% CI: 1.08-5.76, p=0.032) in the patient group.
CONCLUSION: Gastrin values were higher in patients compared to controls. There was no correlation between gastrin levels and treatment duration. Female patients had significantly higher gastrin values than males.
Copyright © 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dyspepsia; GERD; Gastrin; Proton-pump inhibitors

Mesh:

Substances:

Year:  2013        PMID: 24210828     DOI: 10.1016/j.dld.2013.09.021

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  4 in total

1.  Predictors of Gastrin Elevation Following Proton Pump Inhibitor Therapy.

Authors:  Hólmfridur Helgadóttir; Sigrún H Lund; Sveinbjörn Gizurarson; David C Metz; Einar S Björnsson
Journal:  J Clin Gastroenterol       Date:  2020-03       Impact factor: 3.062

Review 2.  Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?

Authors:  Prasanna Santhanam; Sangeeta Chandramahanti; Alexander Kroiss; Run Yu; Philippe Ruszniewski; Rakesh Kumar; David Taïeb
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-13       Impact factor: 9.236

Review 3.  When does proton pump inhibitor treatment become long term? A scoping review.

Authors:  Peter Fentz Haastrup; Dorte Ejg Jarbøl; Wade Thompson; Jane Møller Hansen; Jens Søndergaard; Sanne Rasmussen
Journal:  BMJ Open Gastroenterol       Date:  2021-02

Review 4.  Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?

Authors:  Denis M McCarthy
Journal:  Int J Mol Sci       Date:  2020-01-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.